Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-05-15

FDA Approved: EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE — Original Application (Macleods Pharmaceuticals Limited)

View source ↗

Summary

FDA approved the original application for a generic fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate (FTC/TDF). The product is approved…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Emtricitabine and Tenofovir Disoproxil Fumarate (emtricitabine and tenofovir disoproxil fumarate)

Snippet

ORIG AP for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)